Kyndryl (NYSE: KD), a leading provider of mission-critical enterprise technology services, today announced that research ...

Kyndryl Holdings, Inc. (KD) closed at $30.29 in the latest trading session, marking a +1.47% move from the prior day.

NEW YORK, April 14, 2025 /PRNewswire/ -- Kyndryl (NYSE: KD), a leading provider of mission-critical enterprise technology services, today announced that research company ISG has recognized ...

SO WHAT: If you purchased Kyndryl securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is ...

IT services giant Kyndryl has partnered with Dr Reddy’s Laboratories to revamp the pharmaceutical company’s IT operations ...

Kyndryl Holdings ( KD 12.17%) is the target of a report from a short-seller that accuses the IT infrastructure company of manipulating financial metrics. Investors are heading for the exits, sending ...

Kyndryl's high P/E ratio and negative free cash flow make the stock look overvalued at first glance. The company is knee-deep in restructuring unprofitable contracts left over from the IBM era.

One of the D.C. region’s largest public companies has opened its first office in Canada’s biggest city as part of a larger push to accelerate growth across North America and the United Kingdom.

Kyndryl, a leading provider of mission-critical enterprise technology services, on Monday announced that it has partnered with Hyderabad-based Pharma giant Dr. Reddy’s Laboratories, a leading Indian ...

Update: After this article was published, Kyndryl issued a statement saying the Gotham City report "contains claims that are inaccurate and deliberately misleading." The company said it believes ...